Carregant...
Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy
Erythrodermic psoriasis (EP) is the most serious type of psoriasis with high morbidity and mortality. First-line recommended therapies for EP, cyclosporine and infliximab have significant adverse effects. Cyclosporine increases the risk of hypertension, leucopenia, infections and renal failure. Infl...
Guardat en:
| Publicat a: | BMJ Case Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357920/ https://ncbi.nlm.nih.gov/pubmed/30709830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-226959 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|